Operating Lease, Right-of-Use Asset of CHAMPIONS ONCOLOGY, INC. from 30 Apr 2019 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CHAMPIONS ONCOLOGY, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Apr 2019 to 31 Oct 2025.
  • CHAMPIONS ONCOLOGY, INC. Operating Lease, Right-of-Use Asset for the quarter ending 31 Oct 2025 was $4,348,000, a 23% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

CHAMPIONS ONCOLOGY, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,348,000 -$1,321,000 -23% 31 Oct 2025 10-Q 15 Dec 2025 2026 Q2
Q2 2025 $4,771,000 -$1,192,000 -20% 31 Jul 2025 10-Q 15 Sep 2025 2026 Q1
Q1 2025 $5,080,000 -$1,172,000 -19% 30 Apr 2025 10-Q 15 Dec 2025 2026 Q2
Q4 2024 $5,370,000 -$1,166,000 -18% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q3
Q3 2024 $5,669,000 -$1,147,000 -17% 31 Oct 2024 10-Q 16 Dec 2024 2025 Q2
Q2 2024 $5,963,000 -$1,129,000 -16% 31 Jul 2024 10-Q 13 Sep 2024 2025 Q1
Q1 2024 $6,252,000 -$1,066,000 -15% 30 Apr 2024 10-K 23 Jul 2025 2025 FY
Q4 2023 $6,536,000 -$1,054,000 -14% 31 Jan 2024 10-Q 15 Mar 2024 2024 Q3
Q3 2023 $6,816,000 -$882,000 -11% 31 Oct 2023 10-Q 13 Dec 2023 2024 Q2
Q2 2023 $7,092,000 -$879,000 -11% 31 Jul 2023 10-Q 13 Sep 2023 2024 Q1
Q1 2023 $7,318,000 -$912,000 -11% 30 Apr 2023 10-K 19 Jul 2024 2024 FY
Q4 2022 $7,590,000 -$828,000 -9.8% 31 Jan 2023 10-Q 16 Mar 2023 2023 Q3
Q3 2022 $7,698,000 -$563,000 -6.8% 31 Oct 2022 10-Q 13 Dec 2022 2023 Q2
Q2 2022 $7,971,000 -$358,000 -4.3% 31 Jul 2022 10-Q 12 Sep 2022 2023 Q1
Q1 2022 $8,230,000 -$291,000 -3.4% 30 Apr 2022 10-K 24 Jul 2023 2023 FY
Q4 2021 $8,418,000 +$3,038,000 +56% 31 Jan 2022 10-Q 15 Mar 2022 2022 Q3
Q3 2021 $8,261,000 +$2,734,000 +49% 31 Oct 2021 10-Q 13 Dec 2021 2022 Q2
Q2 2021 $8,329,000 +$2,656,000 +47% 31 Jul 2021 10-Q 13 Sep 2021 2022 Q1
Q1 2021 $8,521,000 +$5,723,000 +205% 30 Apr 2021 10-K 22 Jul 2022 2022 FY
Q4 2020 $5,380,000 +$2,478,000 +85% 31 Jan 2021 10-Q 15 Mar 2021 2021 Q3
Q3 2020 $5,527,000 +$2,523,000 +84% 31 Oct 2020 10-Q 14 Dec 2020 2021 Q2
Q2 2020 $5,673,000 +$2,570,000 +83% 31 Jul 2020 10-Q 14 Sep 2020 2021 Q1
Q1 2020 $2,798,000 +$2,798,000 30 Apr 2020 10-K 26 Jul 2021 2021 FY
Q4 2019 $2,902,000 31 Jan 2020 10-Q 16 Mar 2020 2020 Q3
Q3 2019 $3,004,000 31 Oct 2019 10-Q 16 Dec 2019 2020 Q2
Q2 2019 $3,103,000 31 Jul 2019 10-Q 14 Sep 2020 2021 Q1
Q1 2019 $0 30 Apr 2019 10-Q 16 Dec 2019 2020 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.